Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Roche Holding AG (OTCQX International Premier:RHHVF)

Delayed Data
As of 2:08pm ET
 -5.20 / -2.05%
Today’s Change
Today|||52-Week Range
Mylan Finalizes Settlement Agreement with DOJ for $465M
5:19pm / Zacks.com - Paid Partner Content
Biotech movers: CEL-SCI Leaps After FDA Lets Cancer Study Move Forward
Aug 14 / TheStreet.com - Paid Partner Content
European Pharma Companies Slip on MS Pricing Probe
4:21am / TheStreet.com - Paid Partner Content
Puma (PBYI) Q2 Loss Narrower than Expected, Nerlynx in Focus
Aug 10 / Zacks.com - Paid Partner Content
Exelixis Submits sNDA for Kidney Cancer Drug Cabometyx
Aug 17 / Zacks.com - Paid Partner Content
Mylan (MYL) Misses on Q2 Earnings & Sales, Lowers View
Aug 09 / Zacks.com - Paid Partner Content
Ophthotech's Fovista Combo Regimen Disappoints in Phase III
Aug 16 / Zacks.com - Paid Partner Content
Inovio (INO) Q2 Loss Narrower Than Expected, Revenues Beat
Aug 09 / Zacks.com - Paid Partner Content
Bristol-Myers Opdivo Fails Kidney Cancer Trial CheckMate-214
Aug 16 / Zacks.com - Paid Partner Content
Prothena (PRTA) Q2 Loss Narrows as Roche Makes $30M Payment
Aug 09 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close253.70
Today’s open248.50
Day’s range248.50 - 248.50
Average volume (3 months)5,012
Market cap$178.2B
Dividend yield3.23%
Data as of 2:08pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)+5.53%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+2.67%
P/E ratio--


No competitors data available.


Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$51.3B
Annual profit (last year)$9.7B
Net profit margin18.93%


Health Technology
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Severin Schwan
Chief Financial &
Information Technology Officer
Alan Hippe
Corporate headquarters
Basel, Basel-stadt (basle Town)